<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We previously found that ginsenoside Rd (Rd), one of the major active ingredients in Panax ginseng, protects neuronal cells from <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> and oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation, an in vitro model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we examined the protective effects of Rd in an animal model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Rats administered with Rd or vehicle were subjected to transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>Rd (50 mg/kg) significantly reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 52.8% </plain></SENT>
<SENT sid="4" pm="."><plain>This reduction of injury volume was associated with an improvement in neurological function and was sustained for at least 2 weeks after the induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>To evaluate the underlying mechanisms of Rd against <z:hpo ids='HP_0001297'>stroke</z:hpo>, brain tissues were assayed for <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> enzyme activities, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential (MMP), production of reactive oxygen species (ROS), energy metabolites, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Rd markedly protected mitochondria as indicated by preserved respiratory chain complex activities and aconitase activity, lowered <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> production, and hyperpolarized MMP </plain></SENT>
<SENT sid="7" pm="."><plain>Microdialysis results illustrated that Rd significantly decreased the accumulation of <z:chebi fb="4" ids="24996">lactate</z:chebi>, the end product of anaerobic glycolysis, and increased <z:chebi fb="1" ids="15361">pyruvate</z:chebi>, the end product of aerobic glycolysis, hence inducing a lower <z:chebi fb="4" ids="24996">lactate</z:chebi>/<z:chebi fb="1" ids="15361">pyruvate</z:chebi> ratio </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, in vitro studies further exhibited that Rd protected isolated mitochondria from calcium-induced damage by attenuating <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> swelling, preserving MMP and decreasing ROS production </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, Rd treatment reduced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> release of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> (CytoC) and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing factor (AIF), thereby minimizing mitochondria-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, these findings demonstrated that Rd exerts neuroprotective effects in transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, which may involve an integrated process of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> protection, energy restoration and inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>